Feasibility of a smartphone app for increasing medication adherence

Not Applicable

Completed

• Conditions: Adherence to anti-hypertensive medication; Circulatory System; Essential (primary) hypertension

• Registration Number: ISRCTN96168767
• Lead Sponsor: niversity of Cambridge

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-03-15
• Study Completion: 2021-08-14
• Last Update Posted: 15 January 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 106

Inclusion Criteria

1. Aged 18 years of age and over
2. Prescribed any type of blood pressure lowering medication and attending a participating community pharmacy in the East of England or London during the recruitment period
3. Owns a smartphone (Android or iPhone)
4. Has a valid email address
5. Has an adequate understanding of verbal and written English
6. Is able to provide written informed consent

Exclusion Criteria

1. Is using a pill organiser or similar medication reminder system
2. Is taking part in another research project on medication adherence

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<br> Measured at baseline and follow-up meeting (3 months):<br> 1. The proportion of potential participants who cannot participate because of technology issues but who are otherwise eligible<br> 2. Participation rate (the proportion of eligible patients who agree to take part)<br> 3. The number of participants randomised (in total; per pharmacy; and per month)<br> 4. The proportion of participants in each trial arm who download and install the App (uptake rate)<br> 5. The proportion of participants in each trial arm who use the App for 1 week, 1 month and 3 months<br> 6. The proportion of participants who attend the pharmacy for follow-up and provide complete outcome measures<br> 7. The proportion who drop out, reasons for loss to follow-up<br>

Secondary Outcome Measures

Name	Time	Method
<br> Measured at baseline and follow-up meeting (3 months):<br> 1. Medication adherence measured using Medication Adherence Report Scale (MARS)<br> 2. Systolic blood pressure<br> 3. Health status measured using the EQ5D-5L<br> 4. Resource use (additional visits to the pharmacist as a result of using the App) and health service costs (time taken by pharmacist to explain intervention) measured to inform the economic evaluation in the main trial<br> 5. Use of the study interventions and potential mediators of their effects on medication adherence and systolic blood pressure<br> 6. Feasibility/acceptability of the interventions and of conducting a cost-effectiveness trial using qualitative interviews post-trial<br>